New Whitepaper
Pharma R&D Annual Review 2020
What’s Inside:
The disease focus areas of the top 10 pharma companies
Where in the world R&D is actually occurring
Which company saw the biggest decline in pipeline size
The number of new drug protein targets identified by year
Which big pharma company exhibits the most intense single therapeutic focus
All Rights Reserved. Forward ® 2020
EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA 92008
BACK TO TOP
Discover where R&D is heading as we move into an exciting new decade!
In this new whitepaper, Pharma Intelligence takes a deep dive into the data and assesses industry trends by examining pharmaceutical pipelines by company, therapeutic area, disease, target and drug type.
Brought to you by:
